POMDOCTOR LIMITED American Depositary Shares (POM)
Stock · NASDAQ · Consumer Discretionary
$0.632as of 10/16/2026
Price chart
Active signals
High Beta62.8%
200 SMA Touch0.0%Resistance level
$0.800525
Industry
Other Specialty Stores
About POM
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospit…
- Sector
- Consumer Discretionary
- Industry
- Other Specialty Stores
- Employees
- 165
- Website
- www.7lk.com/
Fundamentals
- 1-day range
- $0.553$0.7167
- Market cap
- $6.01M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-253.34
- Dividend yield
- —
- Beta
- 2.37
- Avg. volume
- 69.2K
52-week range
$0.5$115.74
POMDOCTOR LIMITED American Depositary Shares Competitors
Chosen by industry and closest market cap.
- POMPOMDOCTOR LIMITED American Depositary Shares$0.632▼ 10.86%Market cap $6.01MP/E —$0.5$115.74
- YJYunji Inc. American Depository Shares$1.49▼ 1.97%Market cap $6.06MP/E —$1.11$13.97
- BQBoqii Holding Limited Class A Ordinary Shares$0.601▼ 3.06%Market cap $6.35MP/E —$0.5862$56.1
- WBUYWEBUY GLOBAL LTD. Class A Ordinary Shares$0.747▼ 7.32%Market cap $5.01MP/E —$0.6225$4.96
- TKLFTokyo Lifestyle Co. Ltd. American Depositary Shares$1.51▼ 2.89%Market cap $8.17MP/E 8.70$1.3$3.76
- NEXRNexera Technologies Ltd Ordinary Shares$0.825▼ 6.46%Market cap $1.41MP/E —$0.9103$37.4
- LESLLeslie's Inc. Common Stock$0.047▲ 34.29%Market cap $14.23MP/E —$0.017$12.53
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| POM POMDOCTOR LIMITED American Depositary Shares | $6.01M | — | $0.632 | ▼ 10.86% | $0.5$115.74 |
| YJ Yunji Inc. American Depository Shares | $6.06M | — | $1.49 | ▼ 1.97% | $1.11$13.97 |
| BQ Boqii Holding Limited Class A Ordinary Shares | $6.35M | — | $0.601 | ▼ 3.06% | $0.5862$56.1 |
| WBUY WEBUY GLOBAL LTD. Class A Ordinary Shares | $5.01M | — | $0.747 | ▼ 7.32% | $0.6225$4.96 |
| TKLF Tokyo Lifestyle Co. Ltd. American Depositary Shares | $8.17M | 8.70 | $1.51 | ▼ 2.89% | $1.3$3.76 |
| NEXR Nexera Technologies Ltd Ordinary Shares | $1.41M | — | $0.825 | ▼ 6.46% | $0.9103$37.4 |
| LESL Leslie's Inc. Common Stock | $14.23M | — | $0.047 | ▲ 34.29% | $0.017$12.53 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Goodyear Tire, Cryo-Cell International and 3 Stocks to Watch Heading Into Mondaybenzinga · 10/12/2026
- POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting DeterminationYahoo · 10/9/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/9/2026
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · 10/5/2026
- Why PTC Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving PremarketBenzinga · 10/5/2026
- POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD CommercializationYahoo · 9/30/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 9/25/2026
- POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure ModelYahoo · 9/24/2026
- Pomdoctor Highlights Its Differentiated "Hardware + AI + Payment" Infrastructure ModelBenzinga · 9/24/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
POMDOCTOR highlights AI-driven chronic disease management progress
POMDOCTOR announced an acceleration in its AI-enabled chronic disease management and real-world data commercialization efforts. This strategic update was one of several healthcare stock movements noted in recent pre-market sessions. The company operates within a wide 52-week price range, reflecting the volatility typical of its sector.
POMDOCTOR highlights AI-driven chronic disease management progress. POMDOCTOR announced an acceleration in its AI-enabled chronic disease management and real-world data commercialization efforts. This strategic update was one of several healthcare stock movements noted in recent pre-market sessions. The company operates within a wide 52-week price range, reflecting the volatility typical of its sector.